Lincoln Capital Corp PERNIX THERAPEUTICS HLDGS IN Transaction History

Lincoln Capital Corp

  • $232 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
N/A
-17,000 Closed
0 $0
Q3 2018

Oct 10, 2018
BUY
N/A
17,000 New
17,000 $16,000
Track This Portfolio

Track Lincoln Capital Corp Portfolio

Follow Lincoln Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email